Partner Article
Quantum Pharmaceutical Group Promotes Alison Doering to Group Marketing and Communications Head
Alison Doering has been promoted to Head of Group Marketing and Communications at the Quantum Pharmaceutical Group, a leading manufacturer and provider of niche medicines and services to the healthcare sector. Alison, who reports to Group Commercial Director Brian Fisher, joins the Quantum Pharmaceutical Group senior management team from Protomed - an existing business within the Quantum Group responsible for healthcare solution Biodose®.
Alison will lead all brand and corporate marketing and communications for all businesses within the Group, including Quantum Pharmaceutical, UL Medicines, Protomed and Biodose Services.
Commenting on the promotion, Group Commercial Director, Brian Fisher says: “Alison was instrumental in improving the visibility of the Biodose® medicine management dosing system in her previous role. I am delighted that we were able to promote her from within the organisation to this senior role.”
This was posted in Bdaily's Members' News section by Onyx Health Ltd .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
Our Partners
Time for strategy built on the foundational economy
Why being ‘work-ready’ matters more than ever
The North's future doesn't end at Manchester
Exit or legacy? Why every owner needs a plan
Who speaks up for SMEs when giants get bigger?
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work